Patents by Inventor Pamela Dunn

Pamela Dunn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • polypeptides and corresponding DNA fragments and uses thereof
    Patent number: 7736873
    Abstract: The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector containing a nucleotide sequence encoding a 98 kDa outer membrane protein of a strain of Chlamydia pneumoniae and a promoter to effect expression of the 98 kDa outer membrane protein gene in the host. Modifications are possible within the scope of this invention.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: June 15, 2010
    Assignee: Sanofi Pasteur Limited
    Inventors: Andrew D. Murdin, Raymond P. Oomen, Joe Wang, Pamela Dunn
  • outer membrane protein (OMP) and vaccine uses of the protein
    Patent number: 7662391
    Abstract: The present invention provides vaccines and methods for immunizing a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The vaccine and method employ an OMP (outer membrane protein) of a strain of Chlamydia pneumoniae. Modifications are possible within the scope of this invention.
    Type: Grant
    Filed: June 2, 2005
    Date of Patent: February 16, 2010
    Assignee: Sanofi Pasteur Limited
    Inventors: Andrew D. Murdin, Raymond P. Oomen, Joe Wang, Pamela Dunn
  • Chlamydia antigens and protein vaccine
    Patent number: 7658934
    Abstract: The present invention provides vaccines for immunizing a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The vaccine and method employ a full-length, 5?-truncated or 3?-truncated 76 kDa protein of a strain of Chlamydia pneumoniae. Modifications are possible within the scope of this invention.
    Type: Grant
    Filed: February 9, 2009
    Date of Patent: February 9, 2010
    Assignee: Sanofi Pasteur Limited
    Inventors: Andrew D. Murdin, Raymond P. Oomen, Joe Wang, Pamela Dunn
  • 60 Kda CRMP antigens and vaccine uses
    Patent number: 7629327
    Abstract: The present invention provides vaccines and methods for immunizing a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The vaccine and method employ a 60 kDa cysteine-rich membrane protein of a strain of Chlamydia pneumoniae. Modifications are possible within the scope of this invention.
    Type: Grant
    Filed: September 11, 2007
    Date of Patent: December 8, 2009
    Assignee: Sanofi Pasteur Limited
    Inventors: Andrew D. Murdin, Raymond P. Oomen, Joe Wang, Pamela Dunn
  • antigens and vaccine uses of the protein
    Patent number: 7595058
    Abstract: The present invention provides vaccines and methods for immunizing a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The vaccine and method employ a full-length, 5?-truncated or 3?-truncated 76kDa protein of a strain of Chlamydia pneumoniae. Modifications are possible within the scope of this invention.
    Type: Grant
    Filed: May 2, 2005
    Date of Patent: September 29, 2009
    Assignee: Sanofi Pasteur Limited
    Inventors: Andrew D. Murdin, Raymond P. Oomen, Joe Wang, Pamela Dunn
  • OMP P6 VACCINE FOR TREATING AND PREVENTING CHLAMYDIA INFECTION
    Publication number: 20090214639
    Abstract: The present invention provides a vaccine for immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The vaccine contains a polypeptide comprising an omp P6 precursor sequence of a strain of C. pneumoniae and variants of the sequence. Modifications are possible within the scope of this invention.
    Type: Application
    Filed: May 7, 2009
    Publication date: August 27, 2009
    Applicant: SANOFI PASTEUR LIMITED
    Inventors: Andrew D. Murdin, Raymond P. Oomen, Joe Wang, Pamela Dunn
  • CHLAMYDIA ANTIGENS AND PROTEIN VACCINE
    Publication number: 20090155350
    Abstract: The present invention provides vaccines for immunizing a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The vaccine and method employ a full-length, 5?-truncated or 3?-truncated 76 kDa protein of a strain of Chlamydia pneumoniae. Modifications are possible within the scope of this invention.
    Type: Application
    Filed: February 9, 2009
    Publication date: June 18, 2009
    Applicant: AVENTIS PASTEUR LIMITED
    Inventors: ANDREW D. MURDIN, RAYMOND P. OOMEN, JOE WANG, PAMELA DUNN
  • CHLAMYDIA POLYPEPTIDES AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF
    Publication number: 20090142376
    Abstract: The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector containing a nucleotide sequence encoding a 98 kDa outer membrane protein of a strain of Chlamydia pneumoniae and a promoter to effect expression of the 98 kDa outer membrane protein gene in the host. Modifications are possible within the scope of this invention.
    Type: Application
    Filed: October 31, 2007
    Publication date: June 4, 2009
    Inventors: Andrew D. Murdin, Raymond P. Oomen, Joe Wang, Pamela Dunn
  • Chlamydia 60 kDa CRMP antigens and vaccine uses
    Publication number: 20080113933
    Abstract: The present invention provides vaccines and methods for immunizing a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The vaccine and method employ a 60 kDa cysteine-rich membrane protein of a strain of Chlamydia pneumoniae. Modifications are possible within the scope of this invention.
    Type: Application
    Filed: September 11, 2007
    Publication date: May 15, 2008
    Inventors: Andrew D. Murdin, Raymond P. Oomen, Joe Wang, Pamela Dunn
  • antigens and corresponding DNA fragments and uses thereof
    Patent number: 7335370
    Abstract: The present invention provides a method of immunizing a host against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The method involves nucleic acid immunization, including DNA immunization, and employs a vector containing a nucleotide sequence which encodes an ATP/ADP translocase of a strain of Chlamydia pneumoniae. The nucleotide sequence is operably linked to a promoter to effect expression of the ATP/ADP translocase in the host. The host may be a human host. Modifications are possible within the scope of this invention.
    Type: Grant
    Filed: July 23, 2004
    Date of Patent: February 26, 2008
    Assignee: Aventis Pasteur Limited
    Inventors: Andrew D. Murdin, Raymond P. Oomen, Joe Wang, Pamela Dunn
  • antigens and corresponding DNA fragments and uses thereof
    Patent number: 7326545
    Abstract: The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector containing a nucleotide sequence encoding a 98 kDa outer membrane protein of a strain of Chlamydia pneumoniae and a promoter to effect expression of the 98 kDa outer membrane protein gene in the host. Modifications are possible within the scope of this invention.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: February 5, 2008
    Assignee: Sanofi Pasteur Limited
    Inventors: Andrew D. Murdin, Raymond P. Oomen, Joe Wang, Pamela Dunn
  • Chlamydia antigens and corresponding DNA fragments and uses thereof
    Patent number: 7314869
    Abstract: The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector containing a nucleotide sequence encoding OMP (outer membrane protein) of a strain of Chlamydia pneumoniae and a promoter to effect expression of the OMP (outer membrane protein) gene in the host. Modifications are possible within the scope of this invention.
    Type: Grant
    Filed: December 29, 2003
    Date of Patent: January 1, 2008
    Assignee: Sanofi Pasteur Limited
    Inventors: Andrew D. Murdin, Raymond P. Oomen, Joe Wang, Pamela Dunn
  • antigens and corresponding DNA fragments and uses thereof
    Patent number: 7285276
    Abstract: The present invention provides vaccines and methods for immunizing a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The vaccine and method employ a 60 kDa cysteine-rich membrane protein of a strain of Chlamydia pneumoniae. Modifications are possible within the scope of this invention.
    Type: Grant
    Filed: April 18, 2005
    Date of Patent: October 23, 2007
    Assignee: Sanofi Pasteur Limited
    Inventors: Andrew D. Murdin, Raymond P. Oomen, Joe Wang, Pamela Dunn
  • Chlamydia antigens and corresponding DNA fragments and uses thereof
    Patent number: 7183402
    Abstract: The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector containing a nucleotide sequence encoding a 60 kDa cysteine-rich membrane protein of a strain of Chlamydia pneumoniae and a promoter to effect expression of the 60 kDa cysteine-rich membrane protein gene in the host. Modifications are possible within the scope of this invention.
    Type: Grant
    Filed: November 1, 2004
    Date of Patent: February 27, 2007
    Assignee: Sanofi Pasteur Limited
    Inventors: Andrew D. Murdin, Raymond P. Oomen, Joe Wang, Pamela Dunn
  • Chlamydia antigens and corresponding DNA fragments and uses thereof
    Patent number: 7081245
    Abstract: The present invention provides nucleic acids, proteins and vectors for a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The method employs a vector containing a nucleotide sequence encoding an ATP-binding cassette of a strain of Chlamydia pneumoniae and a promoter to effect expression of the ATP-binding cassette gene product in the host. Modifications are possible within the scope of this invention.
    Type: Grant
    Filed: January 7, 2003
    Date of Patent: July 25, 2006
    Assignee: Sanofi Pasteur Limited
    Inventors: Andrew D. Murdin, Raymond P. Oomen, Joe Wang, Pamela Dunn
  • Chlamydia antigens and corresponding DNA fragments and uses thereof
    Patent number: 7070792
    Abstract: The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector containing a nucleotide sequence encoding full-length, 5?-truncated or 3?-truncated 76 kDa protein of a strain of Chlamydia pneumoniae and a promoter to effect expression of the 76 kDa protein gene in the host. Modifications are possible within the scope of this invention.
    Type: Grant
    Filed: June 30, 2003
    Date of Patent: July 4, 2006
    Assignee: Sanofi Pasteur Limited
    Inventors: Andrew D. Murdin, Raymond P. Oomen, Joe Wang, Pamela Dunn
  • Chlamydia antigens and corresponding DNA fragments and uses thereof
    Patent number: 7019125
    Abstract: The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector containing a nucleotide sequence encoding an omp P6 precursor of a strain of Chlamydia pneumoniae and a promoter to effect expression of the omp P6 precursor in the host. Modifications are possible within the scope of this invention.
    Type: Grant
    Filed: December 31, 2002
    Date of Patent: March 28, 2006
    Assignee: Sanofi Pasteur Limited
    Inventors: Andrew D. Murdin, Raymond P. Oomen, Joe Wang, Pamela Dunn
  • Chlamydia antigens and corresponding DNA fragments and uses thereof
    Publication number: 20050220805
    Abstract: The present invention provides vaccines and methods for immunizing a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The vaccine and method employ an OMP (outer membrane protein) of a strain of Chlamydia pneumoniae. Modifications are possible within the scope of this invention.
    Type: Application
    Filed: June 2, 2005
    Publication date: October 6, 2005
    Inventors: Andrew Murdin, Raymond Oomen, Joe Wang, Pamela Dunn
  • Chlamydia antigens and vaccine uses of the protein
    Publication number: 20050202048
    Abstract: The present invention provides vaccines and methods for immunizing a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The vaccine and method employ a full-length, 5?-truncated or 3?-truncated 76kDa protein of a strain of Chlamydia pneumoniae. Modifications are possible within the scope of this invention.
    Type: Application
    Filed: May 2, 2005
    Publication date: September 15, 2005
    Inventors: Andrew Murdin, Raymond Oomen, Joe Wang, Pamela Dunn
  • Chlamydia antigens and corresponding DNA fragments and uses thereof
    Publication number: 20050186266
    Abstract: The present invention provides vaccines and methods for immunizing a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The vaccine and method employ a 60 kDa cysteine-rich membrane protein of a strain of Chlamydia pneumoniae. Modifications are possible within the scope of this invention.
    Type: Application
    Filed: April 18, 2005
    Publication date: August 25, 2005
    Inventors: Andrew Murdin, Raymond Oomen, Joe Wang, Pamela Dunn